World Molecular Imaging Congress 2017: IMAGinING the Future: from Molecules to Medicine

2017 年世界分子影像大会：想象未来：从分子到医学

• 批准号: 9398016
• 负责人: SANJIV S GAMBHIR
• 金额: $ 1.5万
• 依托单位: WORLD MOLECULAR IMAGING SOCIETY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-07-15 至 2018-07-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9398016
• 关键词: Academy; Area; Biology; California; Cardiology; Chemistry; Clinic; Clinical; Communicable Diseases; Communities; Comprehension; Congresses; Detection; Development; Diagnostic; Disabled Persons; Discipline; Disease; Endocrinology; Equilibrium; Event; Funding; Future; Gender; Goals; Head; Health; Healthcare; Human; Imaging technology; Individual; Industry; Interest Group; International; Intervention; Investigation; Learning; Life; Malignant Neoplasms; Medicine; Mission; Molecular Biology; Neurology; Pathologic Processes; Patient Care; Pennsylvania; Phase; Philadelphia; Physicians; Play; Postdoctoral Fellow; Research Personnel; Rheumatology; Role; Science; Scientist; Secure; Seminal; Societies; Students; Training; Travel; Underrepresented Minority; United States National Institutes of Health; Universities; Woman; Work; anticancer research; career development; cellular imaging; clinical application; clinical imaging; college; cost; graduate student; human disease; image guided therapy; in vivo imaging; innovation; insight; interest; medical specialties; meetings; member; molecular imaging; multidisciplinary; multimodality; next generation; novel; oncology; pre-clinical; professor; prognostic; programs; translational scientist

ABSTRACT Molecular imaging (MI) is finding transformative applications in the understanding, detection and treatment of nearly all human diseases. The field of MI represents a fusion of diverse scientific fields, including imaging technologies, molecular biology, and chemistry, that is providing major new insights and advances to the scientific community. The World Molecular Imaging Society (WMIS) embodies the field of MI as an organization dedicated to developing and promoting preclinical and clinical imaging of various types at the atomic level, to understand and effectively treat often life-threatening diseases of a variety of specialties, such as in oncology, infectious disease, neurology, cardiology, rheumatology, and endocrinology. A distinguishing feature of our society is the highly-integrated, multimodal approach that spans from scientific innovation to patient care in the clinic. As an international scientific educational organization, active members of WMIS include basic and translational scientists, clinicians, young researchers and students from a wide variety of disciplines, with a dedicated common goal to the understanding of biology and medicine through multimodal in vivo imaging of cellular and molecular events involved in normal and pathologic processes and utilization of quantitative MI in patient care. The annual World Molecular Imaging Congress (WMIC) is held for WMIS members and non-members interested in the field, who come from both academics and industry, and is the only comprehensive, international meeting of MI. Indeed, the WMIC is the epitome of MI that provides a platform for scientists and clinicians with diverse backgrounds to interact, present, and discuss and follow cutting-edge advances. The WMIS is actively seeking mechanisms to maintain the impetus and rapid trajectories of this multidisciplinary transformative field, in particular, by securing travel funds for post-doctoral fellows and graduate students. These individuals will play future roles in deciding how MI is utilized in healthcare. The goal of this R13 is to obtain specific funds to cover costs that support the attendance of students at the graduate and postdoctoral levels, especially encouraging women, underrepresented minorities and persons with disabilities, enabling their attendance to the annual WMIC, next year in Philadelphia, Pennsylvania on September 13-16, 2017.

摘要 分子成像(MI)在理解、检测和分析生物多样性方面取得了革命性的应用 治疗几乎所有人类疾病。MI领域代表着不同科学领域的融合 包括成像技术、分子生物学和化学在内的领域，提供了主要的 为科学界带来新的见解和进展。世界分子影像学会 (世界管理信息系统)将管理信息领域体现为一个致力于发展和促进 在原子水平上了解和有效地了解各种类型的临床前和临床影像 治疗经常危及生命的各种专科疾病，如肿瘤学、传染性 疾病、神经学、心脏病学、风湿病学和内分泌学。的一个显著特点 我们的社会是高度整合的多模式方法，从科学创新到 诊所里的病人护理。作为一个国际科学教育组织，活跃的成员 WMI的成员包括基础和翻译科学家、临床医生、青年研究人员和学生 来自广泛的学科，有一个致力于理解生物学的共同目标 和医学通过体内细胞和分子事件的多模式成像 定量心肌梗死的正常和病理过程及其在患者护理中的应用。一年一度的 世界分子成像大会(WMIC)面向世界分子成像协会成员和非成员举行 对该领域感兴趣，来自学术界和工业界，是唯一 MI的综合性国际会议。事实上，WMIC是MI的缩影， 为具有不同背景的科学家和临床医生提供了一个互动、展示、 并讨论和跟踪前沿进展。世界管理信息系统正在积极寻求机制，以 保持这一多学科变革性领域的动力和快速发展， 特别是通过确保博士后研究员和研究生的旅行资金。这些 个人未来将在决定如何在医疗保健中利用MI方面发挥作用。此R13的目标是 是获得特定的资金，以支付支持学生参加研究生课程的费用 和博士后水平，特别是鼓励妇女、代表不足的少数民族和 残疾人，使他们能够参加明年#年的WMIC年度会议 2017年9月13日至16日，宾夕法尼亚州费城。